Moody's Rating for Ansell Capital

MOODY'S ANALYTICS RISK SCORE

6

Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.

BriaCell Therapeutics, Inc. operates as an immuo-oncology company which engages in the development of immunotherapy treatments for cancer. Its technology includes BriaVax, patents, mechanism of action, clinical trials, briadx. The company was founded by Charles L. Wiseman and Isaac B. Maresky on April 3, 2014 and is headquartered in West Vancouver, Canada.